How Oncology Demand Is Shaping the Doxorubicin Hydrochloride Injection Market According to a newly published market research report by 24LifeSciences, global doxorubicin hydrochloride for injection market was valued at USD 1.2 billion in 2026 and is projected to reach USD 1.7 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. Doxorubicin hydrochloride, an essential anthracycline chemotherapeutic agent, is a cornerstone in treating a broad spectrum of cancers, including breast cancer, ovarian cancer, lymphomas, and sarcomas. Its mechanism of action involves intercalating DNA and inhibiting topoisomerase II, thereby disrupting DNA replication and RNA synthesis in rapidly dividing cancer cells. Available primarily in 10mg and 50mg vials, its established efficacy in numerous chemotherapy protocols continues to underpin its critical role in oncology. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10567/doxorubicin-hydrochloride-for-injection-market

Top 10 Key Players Transforming the Global Hydroxyzine Imine Market (2026–2034) According to a newly published market research report by 24LifeSciences, global Hydroxyzine Imine market was valued at USD 797 million in 2026 and is projected to reach USD 1172 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Hydroxyzine Imine, a critical pharmaceutical intermediate, is the precursor in synthesizing hydroxyzine hydrochloride and hydroxyzine pamoate, which are first-generation antihistamines and central nervous system depressants. These final active pharmaceutical ingredients (APIs) are essential for medications primarily indicated to manage anxiety and provide symptomatic relief from pruritus (itching) due to allergic conditions like chronic urticaria and atopic dermatitis. Its established role in allergy and anxiety management continues to underpin its significance in both dermatology and psychiatric therapeutic areas. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9259/hydroxyzine-imine-market